A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This is a study to explore the safety, tolerance and efficacy of AL2846 capsules combined
with mFOLFOLX6 or FOLFIRI standard chemotherapy regimen in subjects with advanced metastatic
colorectal cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Treatments:
Calcium Calcium, Dietary Folic Acid Irinotecan Oxaliplatin Vitamin B Complex